Alzamend Neuro Stock Forward View - Accumulation Distribution
| ALZN Stock | USD 1.87 0.21 10.10% |
Alzamend Stock outlook is based on your current time horizon. Although Alzamend Neuro's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Alzamend Neuro's systematic risk associated with finding meaningful patterns of Alzamend Neuro fundamentals over time.
As of today the rsi of Alzamend Neuro's share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Current Year (2.52) | EPS Estimate Next Year (2.98) | Wall Street Target Price 28 | EPS Estimate Current Quarter (1.96) |
Using Alzamend Neuro hype-based prediction, you can estimate the value of Alzamend Neuro from the perspective of Alzamend Neuro response to recently generated media hype and the effects of current headlines on its competitors.
Alzamend Neuro after-hype prediction price | USD 1.79 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Alzamend Neuro to cross-verify your projections. Alzamend Neuro Additional Predictive Modules
Most predictive techniques to examine Alzamend price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alzamend using various technical indicators. When you analyze Alzamend charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 970.56 | 16133.23 |
| Check Alzamend Neuro Volatility | Backtest Alzamend Neuro | Information Ratio |
Alzamend Neuro Trading Date Momentum
| On February 05 2026 Alzamend Neuro was traded for 1.87 at the closing time. The top price for the day was 2.14 and the lowest listed price was 1.82 . The trading volume for the day was 107.9 K. The trading history from February 5, 2026 did not affect price variability. The overall trading delta against the current closing price is 12.30% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Alzamend Neuro to competition |
Other Forecasting Options for Alzamend Neuro
For every potential investor in Alzamend, whether a beginner or expert, Alzamend Neuro's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Alzamend Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Alzamend. Basic forecasting techniques help filter out the noise by identifying Alzamend Neuro's price trends.Alzamend Neuro Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alzamend Neuro stock to make a market-neutral strategy. Peer analysis of Alzamend Neuro could also be used in its relative valuation, which is a method of valuing Alzamend Neuro by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Alzamend Neuro Market Strength Events
Market strength indicators help investors to evaluate how Alzamend Neuro stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alzamend Neuro shares will generate the highest return on investment. By undertsting and applying Alzamend Neuro stock market strength indicators, traders can identify Alzamend Neuro entry and exit signals to maximize returns.
| Accumulation Distribution | 16133.23 | |||
| Daily Balance Of Power | (0.66) | |||
| Rate Of Daily Change | 0.9 | |||
| Day Median Price | 1.98 | |||
| Day Typical Price | 1.94 | |||
| Price Action Indicator | (0.21) | |||
| Period Momentum Indicator | (0.21) |
Alzamend Neuro Risk Indicators
The analysis of Alzamend Neuro's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Alzamend Neuro's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting alzamend stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.91 | |||
| Standard Deviation | 4.07 | |||
| Variance | 16.53 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Alzamend Neuro
The number of cover stories for Alzamend Neuro depends on current market conditions and Alzamend Neuro's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Alzamend Neuro is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Alzamend Neuro's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Alzamend Neuro Short Properties
Alzamend Neuro's future price predictability will typically decrease when Alzamend Neuro's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Alzamend Neuro often depends not only on the future outlook of the potential Alzamend Neuro's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alzamend Neuro's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 450.8 K | |
| Cash And Short Term Investments | 3.9 M |
Check out Historical Fundamental Analysis of Alzamend Neuro to cross-verify your projections. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Will Biotechnology sector continue expanding? Could Alzamend diversify its offerings? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alzamend Neuro data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Alzamend Neuro's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alzamend Neuro represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Alzamend Neuro's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.